Iterum Therapeutics plc Announces Result of Proposal 8 at Annual General Meeting

NEXT STORY
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Moderna, Inc. (MRNA) Investors of Ongoing Investigation into Possible Securities Fraud and Insider Trading, Encourages Investors with Significant Losses to Contact Firm
PREV STORY
BioXcel Therapeutics to Participate in Two Upcoming Investor Conferences
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aprea Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Update on Business Operations

author_avatar
NASDAQ Market News

Aclaris Therapeutics Announces Formation of New Scientific Advisory Board

author_avatar
NASDAQ Market News

Y-mAbs Announces Data to be Presented at 2020 ASCO Annual Meeting

author_avatar
NASDAQ Market News